VAM
CHTP

Visium Asset Management’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Visium Asset Management’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-931,134
Closed -$5.14M – 1288
2014
Q1 		$5.14M Sell
931,134
-568,866
-38% -$2.86M 0.08% 231
2013
Q4 		$6.64M Buy
+1,500,000
New +$5.07M 0.13% 153

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Visium Asset Management's CHTP Position: Q2 2014 in Review

Visium Asset Management sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 931,134 shares — an estimated $5.14M sold.

Visium Asset Management first reported a position in CHTP in Q4 2013 and held it in 2 quarters. The position peaked at $6.64M in Q4 2013. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Visium Asset Management reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Visium Asset Management sold 931,134 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $5.14M.
  • Visium Asset Management first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q4 2013 and held it in 2 quarters.
  • Visium Asset Management's CHELSEA THERAPEUTICS INT'L LTD position peaked at $6.64M in Q4 2013.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.